The impact of educational and medical systems on autistic children from multilingual American homes: A systematic review.

LAY ABSTRACT: Research has found that autistic children can navigate multilingual schools and communities without harming their language skills or school success. However, they may encounter specific challenges within the United States, where educational and healthcare systems are insufficiently equipped to meet their needs. This review examined 46 US-based studies on the topic and findings reveal persistent deficit-based ideas about multilingualism and autism (e.g., professionals recommending that autistic students only speak and learn in English) accompanied by patterns of unequal identification of autism among multilingual children. These findings highlight issues of disproportionality and inadequate access to educational and healthcare resources. However, recent studies indicate that incorporating a child's native language in education not only enhances learning and behavioral outcomes but also boosts cognitive functions like problem-solving and planning. Taken as a whole, current research suggests that intentionally addressing linguistic diversity will allow educational and medical systems to better serve autistic children.

A Systematic Literature Review of Racial Disproportionality in Autism in the U.S.

In recent years, the Autism and Developmental Disabilities Monitoring Network has observed a shift in racial disparities in autism. To delineate the historical shift of racial disproportionality in US autism prevalence, our literature review examines three key topics: publication trends concerning racial disproportionality in autism, discernible national and state-level patterns, and underlying factors contributing to the disproportionality. Using the PRISMA framework, we synthesized 24 empirical studies on racial disproportionality in autism and its change over time. These studies explored national patterns and spatiotemporal variations to provide a comprehensive understanding of racial disparities in autism. Studies indicated similar national patterns for Black and Asian racial groups; both groups had had mixed results around the turn of the millennium. By 2007, the Asian group was overrepresented again. Hispanic and Native American groups have consistently been underrepresented. However, significant spatiotemporal variations were found, suggesting that these disparities might reflect inherent inequalities within the current identification and classification system. The patterns of racial disproportionality in autism seem to be influenced by numerous factors. These include varying state definitions of autism, disparities in resource distribution, differences in symptom recognition across cultures, service preferences, cultural mismatches between professionals and families, and prevailing biases and stigmas, as revealed by the reviewed studies. These findings prompt a closer look into the causes and implications of these disparities, offering the underlying issues within the current diagnostic system and highlighting the need for further research to ensure equal educational opportunities regardless of disabilities and race/ethnicity.

Treatment of debilitating cremasteric synkinesia with intracremasteric botulinum-A toxin injections.

OBJECTIVE: To describe the surgical technique of botulinum-A toxin injection into the cremasteric muscles of a 26-year-old male with bilateral cremasteric muscle spasms causing significant pain and limitation of activity. This pain has been refractory to multiple previous therapies, including inguinal nerve blocks and bilateral orchidopexies with cremasteric muscle lysis. Multiple imaging modalities revealed no obvious pathology for this significant bilateral pain. Genitourinary examination revealed hyper-retractile testes with changes consistent with bilateral orchidopexies and was otherwise normal. MATERIAL AND METHODS: The patient has undergone 3 outpatient staged injections of botulinum-A toxin into the bilateral cremasteric muscles after spermatic cord block with 1% lidocaine. One hundred units of botulinum-A toxin mixed into 10 mL of sterile normal saline were used for each injection staged 6 weeks apart. RESULTS: The patient tolerated all injections without apparent side effects. After the first injection into his left side, his baseline pain scores were reduced from 8 out of 10 to 3 out of 10 on a standard 10-point pain scale. He reported maximal efficacy 2 weeks after each injection, with dissipation over 4-6 weeks. After 2 left-sided and 1 right-sided injections, his baseline pain was 2 to 4 of 10, equal bilaterally, and he was back to rigorous activity with some limitations. CONCLUSION: Direct injection of botulinum-A toxin into the cremasteric muscle is a viable treatment option for the rare patient with debilitating and painful cremasteric spasms refractory to other therapies.

"Empty" sac in pregnant women with bleeding: are measurements answering the right question?

PURPOSE: To assess the percentage of first-trimester pregnancies with bleeding that demonstrate a visible sac but lack an identifiable embryo and have a mean sac diameter (MSD) in the controversial range of 16-20 mm. METHODS: Retrospective study of all first-trimester sonograms among women with vaginal bleeding during a 4-year interval. RESULTS: The study cohort consisted of 546 first- trimester sonograms. An embryo was not seen in 132 cases (24%). Of these, the MSD in 69 cases (52%) was <16 mm, between 16 and 19 mm in 20 cases (15%), or >or=20 mm in 39 cases (30%). The percentage of women who were threatening to abort who demonstrated a visible sac but lacked an identifiable embryo and had a MSD in the controversial range of 16-20 mm was 3.7% (20/546). CONCLUSION: We found that of 546 sonograms undertaken in pregnant women with vaginal bleeding in the first trimester, only 20 patients (3.7%) fell in the MSD range of 16-20 mm. Therefore, even among those diagnosticians who adopt the most stringent criterion (MSD = 20 mm), an additional examination would be requested in fewer than 1 in 25 patients.

Five-millimeter and smaller embryos without embryonic cardiac activity: outcomes in women with vaginal bleeding.

OBJECTIVE: The purpose of this study was to assess outcomes in embryos with a crown-rump length (CRL) of 5 mm or less without embryonic cardiac activity (ECA) among pregnant women with vaginal bleeding in the first trimester. METHODS: A retrospective study of all first-trimester sonograms in women with vaginal bleeding from 1999 to 2002 was conducted. RESULTS: Thirty-seven embryos without detectable ECA that had a CRL of 5 mm or less were identified. All resulted in pregnancy failure. The breakdown of these embryos by CRL was as follows: 13 were 5 mm; 10 ranged from 4 to 4.9 mm; 11 ranged from 3 to 3.9 mm; and 3 ranged from 2 to 2.9 mm. CONCLUSIONS: In pregnant women with vaginal bleeding, embryos of 5 mm and smaller without a heartbeat all resulted in pregnancy failure.

Application of evidence-based practice through a float project.

Evidence-based practice must become a common, acceptable process for the bedside nurse. This paper demonstrates a process for engaging nurses in the use of evidence for direct practice. An example using the revision of a float policy is provided as a model for staff nurses to incorporate evidence in a mechanism to elicit change.

Safety of prescribing PDE-5 inhibitors via e-medicine vs traditional medicine.

OBJECTIVE: To determine the safety of a US-based, state-regulated Internet system vs a multispecialty primary care system for prescribing phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction. PATIENTS AND METHODS: From January 1, 2001, through December 31, 2005, 500 e-medicine clients (mean+/-SD age, 47+/-11 years; hypertension, 60%; type 2 diabetes mellitus, 2%; mean+/-SD number of medications, 0.4+/-0.8) vs 500 traditional medicine patients (mean+/-SD age, 57+/-12 years; hypertension, 50%; type 2 diabetes mellitus, 23%; mean+/-SD number of medications, 5.1+/-3.1) with erectile dysfunction symptoms were assessed. Noninferiority safety was assessed in this retrospective, cross-sectional study with stratified random sampling by identification of prescribing in the presence of clinically important PDE-5 inhibitor drug interactions with or without high-risk cardiovascular disease, by asking about diagnostic symptoms specific to erectile dysfunction, and by determining frequency of patient counseling. RESULTS: Noninferiority of the e-medicine system was shown for the 6 safety end points, relative to a traditional medicine system. Numbers of inappropriate prescriptions, after correction for disease and medication covariates, did not differ between systems. Medication counseling showed superiority of the e-medicine system. Standard diagnostic questions were required for e-medicine prescribing but were infrequently asked in traditional medicine. CONCLUSION: Safety in prescribing PDE-5 inhibitors for erectile dysfunction was similar between a US-based, state-regulated Internet prescribing system and a multispecialty primary care system.